Samil Pharm (000520) — Cash Flow Reinvestment Rate
Samil Pharm (000520) has a Cash Flow Reinvestment Rate of 2.71x as of June 2025, reinvesting ₩6.62 Billion (capex ₩3.26 Billion plus investments ₩-3.36 Billion) from operating cash flow of ₩2.44 Billion. Explore Samil Pharm capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Samil Pharm Cash Flow Reinvestment Rate (2012–2024)
Historical reinvestment intensity for Samil Pharm across 10 annual periods. Also explore 000520 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Samil Pharm (2012–2024)
Year-by-year capital reinvestment analysis for Samil Pharm. For live market cap and broader valuation context, see Samil Pharm stock valuation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.62x | ₩11.97 Billion | ₩2.59 Billion | ₩5.61 Billion | ▲ +22.9% |
| 2023 | 3.76x | ₩44.17 Billion | ₩11.75 Billion | ₩24.39 Billion | ▼ -73.9% |
| 2022 | 14.38x | ₩59.74 Billion | ₩4.15 Billion | ₩48.48 Billion | ▼ -52.2% |
| 2021 | 30.09x | ₩42.63 Billion | ₩1.42 Billion | ₩32.83 Billion | ▲ +711.2% |
| 2020 | 3.71x | ₩28.83 Billion | ₩7.77 Billion | ₩17.02 Billion | ▲ +117.0% |
| 2019 | 1.71x | ₩18.10 Billion | ₩10.59 Billion | ₩13.89 Billion | ▼ -84.7% |
| 2017 | 11.19x | ₩42.41 Billion | ₩3.79 Billion | ₩36.33 Billion | ▲ +762.2% |
| 2016 | 1.30x | ₩7.31 Billion | ₩5.63 Billion | ₩4.45 Billion | ▼ -69.9% |
| 2015 | 4.31x | ₩12.60 Billion | ₩2.92 Billion | ₩2.36 Billion | ▲ +1035.7% |
| 2012 | 0.38x | ₩1.91 Billion | ₩5.02 Billion | ₩1.91 Billion | — |